AGNP Board Exam – Sexually Transmitted Diseases Prescription(Questions And Answers)
AGNP Board Exam – Sexually Transmitted Diseases Prescription(Questions And Answers) 1. Question: Which of the following is NOT recommended as an alternative treatment for bacterial vaginosis? Intramuscular ceftriaxone (Rocephin) Correct Clindamycin (Cleocin) vaginal cream Metronidazole (Flagyl) vaginal cream Tinidazole (Tindamax) orally Explanation: Intramuscular ceftriaxone (Rocephin) is not indicated in the treatment of bacterial vaginosis. Metronidazole (Flagyl) vaginal cream may be used if metronidazole oral is ineffective or not well tolerated. Alternative regimens include several tinidazole regimens or clindamycin (oral or intravaginal). 2. Question: The recommended empiric treatment of pelvic inflammatory disease is: penicillin G benzathine (Bicillin) intramuscularly plus ceftriaxone (Rocephin) intramuscularly. azithromycin (Zithromax) orally plus ceftriaxone (Rocephin) intramuscularly. ceftriaxone (Rocephin) intramuscularly plus doxycycline (Vibramycin). Correct metronidazole (Flagyl) plus ofloxacin (Floxin). Explanation: The recommended empiric treatment for mild to moderate symptoms of pelvic inflammatory disease (PID) is ceftriaxone (Rocephin) 250 mg intramuscularly plus doxycycline (Vibramycin) 100 mg twice daily x 14 days with or without metronidazole (Flagyl) 500 mg PO twice daily x 14 days. All regimens used to treat PID should also be effective against Neisseria gonorrhoeae and Chlamydia trachomatis because negative endocervical screening for these organisms does not rule out upper-reproductive tract infection. 3. Question: For the treatment of chlamydia, azithromycin (Zithromax) should be given: as one-time dose. Correct daily for 3 days. daily for 5 days. daily for 7 days.
Document information
- Uploaded on
- February 9, 2023
- Number of pages
- 29
- Written in
- 2022/2023
- Type
- Exam (elaborations)
- Contains
- Questions & answers